Anavex Life Sciences (AVXL) Amortization of Deferred Charges (2010 - 2014)
Anavex Life Sciences recorded quarterly Amortization of Deferred Charges of $1.1 million in Q3 2014, up 12485.5% quarter-over-quarter from $8848.0 in Q2 2014.
Anavex Life Sciences' Amortization of Deferred Charges history runs 4 years deep, the most recent figure standing at $1.1 million for Q3 2014.
- In Q3 2014, Amortization of Deferred Charges changed N/A year-over-year to $1.1 million; the TTM figure through Jun 2015 stood at $1.1 million (up 11083.56% YoY), while the FY2014 annual figure was $1.1 million, up 92378.35% from the prior year.
- Amortization of Deferred Charges came in at $1.1 million for Q3 2014 at Anavex Life Sciences, up from $8848.0 in the prior quarter.
- In the past five years, Amortization of Deferred Charges ranged from a high of $1.1 million in Q3 2014 to a low of $1199.0 in Q1 2014.
- A 4-year average of $126207.7 and a median of $17449.0 in 2011 frame the typical range for Amortization of Deferred Charges.
- Across the five-year window, Amortization of Deferred Charges soared 46.91% in 2011 and slumped 96.22% in 2012, its largest moves.
- Anavex Life Sciences' Amortization of Deferred Charges stood at $30315.0 in 2010, then tumbled by 35.17% to $19654.0 in 2011, then slumped by 93.82% to $1215.0 in 2012, then jumped by 91551.44% to $1.1 million in 2014.
- According to Business Quant data, Amortization of Deferred Charges over the past three periods registered $1.1 million, $8848.0, and $1199.0 for Q3 2014, Q2 2014, and Q1 2014 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Anavex Life Sciences | 266.20 Mn | 134.45 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2014 | 1.11 Mn |
| Sep 30, 2014 | 1.11 Mn |
| Jun 30, 2014 | 8,848.00 |
| Jun 30, 2014 | 8,848.00 |
| Mar 31, 2014 | 1,199.00 |
| Mar 31, 2014 | 1,199.00 |
| Dec 31, 2012 | 1,215.00 |
| Dec 31, 2012 | 1,215.00 |
| Sep 30, 2012 | 1,685.00 |
| Sep 30, 2012 | 1,685.00 |
| Jun 30, 2012 | 15,244.00 |
| Jun 30, 2012 | 15,244.00 |
| Mar 31, 2012 | 25,816.00 |
| Mar 31, 2012 | 25,816.00 |
| Dec 31, 2011 | 19,654.00 |
| Dec 31, 2011 | 19,654.00 |
| Sep 30, 2011 | 44,536.00 |
| Sep 30, 2011 | 44,536.00 |
| Sep 30, 2010 | 30,315.00 |
| Sep 30, 2010 | 30,315.00 |